Intelicare Holdings Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Intelicare Holdings's earnings have been declining at an average annual rate of -1.2%, while the Healthcare Services industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 5.3% per year.
Belangrijke informatie
-1.2%
Groei van de winst
24.2%
Groei van de winst per aandeel
| Healthcare Services Groei van de industrie | 42.6% |
| Inkomstengroei | 5.3% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -795.2% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Intelicare Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -2 | 2 | 0 |
| 31 Mar 24 | 0 | -2 | 2 | 0 |
| 31 Dec 23 | 0 | -1 | 2 | 0 |
| 30 Sep 23 | 0 | -2 | 2 | 0 |
| 30 Jun 23 | 0 | -3 | 2 | 0 |
| 31 Mar 23 | 0 | -4 | 2 | 0 |
| 31 Dec 22 | 0 | -4 | 2 | 0 |
| 30 Sep 22 | 0 | -4 | 2 | 0 |
| 30 Jun 22 | 0 | -4 | 2 | 0 |
| 31 Mar 22 | 0 | -4 | 3 | 0 |
| 31 Dec 21 | 0 | -5 | 3 | 0 |
| 30 Sep 21 | 0 | -5 | 3 | 0 |
| 30 Jun 21 | 0 | -4 | 3 | 0 |
| 31 Mar 21 | 0 | -3 | 2 | 0 |
| 31 Dec 20 | 1 | -2 | 1 | 0 |
| 30 Sep 20 | 0 | -2 | 1 | 0 |
| 30 Jun 20 | 0 | -3 | 1 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 1 |
| 30 Jun 18 | 0 | 0 | 0 | 0 |
Kwaliteitswinsten: ICR is currently unprofitable.
Groeiende winstmarge: ICR is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ICR is unprofitable, and losses have increased over the past 5 years at a rate of 1.2% per year.
Versnelling van de groei: Unable to compare ICR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: ICR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17.7%).
Rendement op eigen vermogen
Hoge ROE: ICR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.